technetium tc 99m nanocolloid
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Nov 24, 2020 (NCT04487912)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Also known as
- nanocoll
- nanocoll
- tc-99m-nanocolloid
- technetium tc 99m nanocolloid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04487912 | Phase 4 | Nov 24, 2020 | Ghent University, Norgine |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ghent University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Norgine | For profit | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1